IDH2 and acute myeloid leukemia: Notably, cytosine methylation signatures of TET2-mutated AML show significant overlaps with those found in IDH1/IDH2 mutated patients and IDH1/IDH2 and TET2 mutations are mutually exclusive in AML (8), signaling a common mechanism of leukemogenesis based on aberrant DNA methylation.